A phase IIb randomized control trial of Micronised tissue allografts (AmnioFix®) for the treatment of plantar fasciitis

Trial Profile

A phase IIb randomized control trial of Micronised tissue allografts (AmnioFix®) for the treatment of plantar fasciitis

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 02 Aug 2017

At a glance

  • Drugs DHACM (Primary)
  • Indications Plantar fasciitis
  • Focus Therapeutic Use
  • Most Recent Events

    • 02 Aug 2017 According to a MiMedx media release, Based on exceptional interim results, company has submitted a summary results amendment along with a formal request to the FDA for closure and unblinding of its Plantar Fasciitis Phase 2B trial.
    • 02 Aug 2017 Interim results published in a MiMedx media release.
    • 02 Aug 2017 Status changed from recruiting to active, no longer recruiting, according to a MiMedx media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top